Synovus Financial’s BeOne Medicines Ltd ONC Stock Holding History

Synovus Financial’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4	Closed	–	–	2174
2020 Q1	$0	Buy	+4	New	+$626	﹤0.01%	2241

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Synovus Financial's ONC Position: Q2 2020 in Review

Synovus Financial sold out of BeOne Medicines Ltd (ONC) in Q2 2020, closing a stake of 4 shares.

Synovus Financial first reported a position in ONC in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 220 funds tracked by Wall St. Rank hold ONC as of Q2 2020.

Synovus Financial reported no remaining BeOne Medicines Ltd position as of Q2 2020 after selling out during the quarter.
Synovus Financial sold 4 BeOne Medicines Ltd shares in Q2 2020.
Synovus Financial first reported a position in BeOne Medicines Ltd in Q1 2020 and held it in 1 quarter.
Synovus Financial's BeOne Medicines Ltd position peaked at $0 in Q1 2020.
220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.